Publication | Closed Access
Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry
65
Citations
18
References
2020
Year
After 52 weeks, ustekinumab demonstrated effectiveness in inducing clinical and endoscopic remission in patients with refractory CD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1